Softwr

Healthcare · head to head

Bahmni vs Therapixel

Bahmni logo

Bahmni

Healthcare

Open source hospital information system and EMR for low-resource hospitals, built on OpenMRS

From
Free
Rated
-
Full reviewWebsite
Therapixel logo

Therapixel

Healthcare

French mammography AI with FDA clearances for 2D and tomosynthesis breast screening

From
On request
Rated
-
Full reviewWebsite

The short version

  • Only Bahmni has a free tier, so it costs nothing to try first.
  • Each has a real cost: Bahmni the licence is free and the implementation is not; configuration, data migration, training and multi-year support from a partner routinely cost far more than a small commercial system would have, and hospitals that budget only for hardware stall.; Therapixel european and American regulatory positions were established under different regimes, and under the EU Medical Device Regulation this class of diagnostic AI faces a higher classification and notified body scrutiny, so European buyers must verify the current MDR certificate and expiry rather than relying on a legacy CE reference.
  • They diverge on capability: Bahmni covers OpenMRS clinical record, Therapixel covers MammoScreen 2D.
  • Prices and features above were last checked on 1 September 2026.

Where they differ

Only the attributes on which Bahmni and Therapixel actually diverge.

Attributes where Bahmni and Therapixel differ
AttributeBahmniTherapixel
Starting priceFreeOn request
Pricing modelOpen source, no licence feequote
Free tierYesNo
PlatformsWeb, Linux, AndroidWeb

Identical on both: user rating (Not yet rated), category (Healthcare).

What each one covers

Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.

Only in Bahmni

  • OpenMRS clinical record
  • Configurable clinical forms
  • Laboratory integration
  • Billing and inventory
  • Imaging
  • Inpatient management
  • Offline-capable clinical app
  • Reporting

Only in Therapixel

  • MammoScreen 2D
  • MammoScreen DBT
  • One to ten suspicion score
  • Summary report
  • Workstation and PACS delivery
  • Reading workflow configurations

What people use each for

The jobs each tool is most often brought in to do.

Bahmni

  • A mission or charitable hospital in India or East Africa that cannot fund a commercial hospital information system licence but needs a real EMR rather than papernot Therapixel
  • A ministry of health standardising district hospitals on one system and required by donors to use a recognised Digital Public Goodnot Therapixel
  • An NGO health network wanting one clinical record across several facilities with reporting that can feed a national DHIS2 instancenot Therapixel
  • A hospital that needs the clinical record, laboratory, pharmacy and billing to share one patient identity rather than running four disconnected systemsnot Therapixel

Therapixel

  • A European breast screening programme running mandatory double reading that wants to evaluate AI as a concurrent or second reader within what national guidance permitsnot Bahmni
  • An American breast centre that has moved to tomosynthesis and needs reading support on DBT specifically, which Therapixel holds a clearance fornot Bahmni
  • A screening service wanting a graded suspicion score rather than a binary flag so readers can calibrate their own thresholdnot Bahmni
  • A radiology group evaluating multiple mammography AI vendors head to head on their own historic case set before committingnot Bahmni

Where each one falls short

Documented limitations, not opinions. Every one is a constraint you would hit in normal use.

Bahmni

  • The licence is free and the implementation is not; configuration, data migration, training and multi-year support from a partner routinely cost far more than a small commercial system would have, and hospitals that budget only for hardware stall.
  • There is no single vendor with an obligation to you unless you contract one, so upgrade timing, security patching and defect resolution depend on whichever partner you hired and how long they stay engaged.
  • It integrates four substantial open source systems, which means an upgrade touches OpenMRS, OpenELIS, Odoo and the imaging stack together, and hospitals with heavy customisation often freeze on an old version rather than risk it.
  • Skilled Bahmni implementers are concentrated in a small number of firms in India and a few African countries, so a hospital outside those markets may find nobody local who can support it.
  • Funding for the coalition and its shared engineering comes from donors and member contributions rather than licence revenue, which makes the pace of core development dependent on grant cycles rather than on customer demand.

Therapixel

  • European and American regulatory positions were established under different regimes, and under the EU Medical Device Regulation this class of diagnostic AI faces a higher classification and notified body scrutiny, so European buyers must verify the current MDR certificate and expiry rather than relying on a legacy CE reference.
  • MammoScreen does mammography only, so a hospital wanting AI across head CT, chest and breast needs several vendors and several PACS integrations, or an orchestration layer bought from someone else.
  • Therapixel is a small French company competing against Hologic and iCAD, which have incumbency inside the mammography reading workstation, so integration into an American breast centre is more work than it is for the workstation vendor own AI.
  • Detection performance is sensitive to the mammography unit vendor and acquisition protocol, so published results do not transfer between estates and each site needs local validation it must fund itself.
  • Whether AI can substitute for one of two human readers is a national workforce and liability question, not a product capability, so the labour saving that justifies the purchase in one country is not permitted in another.

Pricing, plan by plan

Bahmni

Free
  • BahmniFree
    • AGPL open source, no licence fee
    • All modules included
    • Community support via forum and documentation

Therapixel

On request
  • MammoScreen$undefined/year
    • Priced per examination or by annual screening volume
    • 2D and tomosynthesis licensed by the versions cleared for each
    • Cloud or on premises deployment quoted differently

Which should you pick?

Choose Bahmni if

  • You need openmrs clinical record.
  • You want to start without paying.
  • You work on Web, Linux, Android.
  • You also want configurable clinical forms.
Bahmni review

Choose Therapixel if

  • You need mammoscreen 2d.
  • You also want mammoscreen dbt.
Therapixel review

Questions people ask

Is Bahmni or Therapixel better?
Neither clearly leads. Bahmni starts at Free and Therapixel at On request, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
Which is cheaper, Bahmni or Therapixel?
Bahmni has a free tier; the other does not. Paid plans start at Free for Bahmni and On request for Therapixel.
Does Bahmni or Therapixel run on more platforms?
Bahmni runs on Web, Linux, Android. Therapixel runs on Web.
Can I use Bahmni for free?
Yes. Bahmni has a free tier, so you can try it without paying. Therapixel starts at On request.
What is Bahmni best used for?
Bahmni is most often used for a mission or charitable hospital in india or east africa that cannot fund a commercial hospital information system licence but needs a real emr rather than paper, a ministry of health standardising district hospitals on one system and required by donors to use a recognised digital public good, an ngo health network wanting one clinical record across several facilities with reporting that can feed a national dhis2 instance, a hospital that needs the clinical record, laboratory, pharmacy and billing to share one patient identity rather than running four disconnected systems. Of those, a mission or charitable hospital in india or east africa that cannot fund a commercial hospital information system licence but needs a real emr rather than paper and a ministry of health standardising district hospitals on one system and required by donors to use a recognised digital public good are not what Therapixel is typically brought in for.
What can Bahmni do that Therapixel cannot?
Bahmni covers OpenMRS clinical record, Configurable clinical forms, Laboratory integration, Billing and inventory. Therapixel covers MammoScreen 2D, MammoScreen DBT, One to ten suspicion score, Summary report.

Answered from the vendors’ own pages

Bahmni: Is Bahmni free?

The software is, under an open source licence. Implementation, hosting, configuration, training and support are charged by whichever partner you engage.

Therapixel: Is MammoScreen FDA cleared?

Yes. It holds 510(k) clearance K192854 for two dimensional mammography from July 2020, a November 2021 clearance for digital breast tomosynthesis, and two further clearances in October 2024 for later versions.

Bahmni: Who owns and governs Bahmni?

Thoughtworks transferred ownership in October 2017 to the Bahmni Coalition, under the fiscal sponsorship of the non-profit OpenMRS Inc. Thoughtworks remains on the governing committee.

Therapixel: Is it CE marked?

Yes, but European buyers should ask specifically for the current certificate under the Medical Device Regulation and its expiry date, because this class of diagnostic AI moved to a higher classification under MDR.

Bahmni: What does an implementation actually cost?

It varies by hospital size and country, but expect the dominant costs to be partner services, training and multi-year support rather than software or hardware. Get a fixed-scope quote covering upgrades, not just go-live.

Therapixel: What does the one to ten score mean?

It is a graded suspicion score per finding and per study, designed to be integrated alongside a radiologist BI-RADS assessment rather than treated as a positive or negative result.

Bahmni: Is it a recognised Digital Public Good?

Yes, Bahmni is on the Digital Public Goods Alliance register, which is increasingly a condition of donor funding for health information systems.

Therapixel: Does it cover anything besides mammography?

No. It is a mammography product only, including tomosynthesis. Other body regions need a different vendor.

Bahmni: Where is it used?

More than 500 implementations across roughly 50 countries, concentrated in South Asia and Africa.

Share

Related pages

More on Bahmni

More on Therapixel

Keep looking

Other head to heads